Patents by Inventor Panayotis G. Katsoyannis

Panayotis G. Katsoyannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatospecific insulin analogues
    Patent number: 5208217
    Abstract: New insulin analogues have now been synthesized and found to be hepatospecific. These insulin analogues contain substitutions for oneThis invention was made with government support under grant #DK-12925 awarded by the National Institutes of Health. The government has certain rights in the invention.
    Type: Grant
    Filed: October 29, 1991
    Date of Patent: May 4, 1993
    Assignee: Mount Sinai School of Medicine of The City University of New York
    Inventor: Panayotis G. Katsoyannis
  • Superactive human insulin analogues
    Patent number: 4992417
    Abstract: Superactive insulin analogues are provided. These insulin analogues are used in therapeutically effective amounts in the preparation of pharmaceutical compositions for administration to diabetic patients.
    Type: Grant
    Filed: November 18, 1988
    Date of Patent: February 12, 1991
    Assignee: Mount Sinai School of Medicine
    Inventors: Panayotis G. Katsoyannis, Gerald P. Schwartz
  • Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
    Patent number: 4992418
    Abstract: A superactive insulin analogue of the formula ##STR1## is provided. This analogue is used in therapeutically effective amounts in the preparation of pharmaceutical compositions for administration to diabetic patients.
    Type: Grant
    Filed: July 17, 1987
    Date of Patent: February 12, 1991
    Assignee: Mount Sinai School of Medicine
    Inventors: Panayotis G. Katsoyannis, Gerald P. Schwartz